206 related articles for article (PubMed ID: 36795945)
1. Potential therapeutic action of tauroursodeoxycholic acid against cholestatic liver injury via hepatic Fxr/Nrf2 and CHOP-DR5-caspase-8 pathway.
Song G; Weng F; Zou B; Zhao J; Jin J; Yan D; Huang K; Sun X; Liu C; Hu Y; Li Y; Qiu F
Clin Sci (Lond); 2023 Apr; 137(7):561-577. PubMed ID: 36795945
[TBL] [Abstract][Full Text] [Related]
2. The choleretic role of tauroursodeoxycholic acid exacerbates alpha-naphthylisothiocyanate induced cholestatic liver injury through the FXR/BSEP pathway.
Zhao J; Song G; Weng F; Li Y; Zou B; Jin J; Yan D; Sun X; Liu C; Qiu FR
J Appl Toxicol; 2023 Jul; 43(7):1095-1103. PubMed ID: 36787806
[TBL] [Abstract][Full Text] [Related]
3. Oleanolic acid alleviates ANIT-induced cholestatic liver injury by activating Fxr and Nrf2 pathways to ameliorate disordered bile acids homeostasis.
Liu J; Liu J; Meng C; Huang C; Liu F; Xia C
Phytomedicine; 2022 Jul; 102():154173. PubMed ID: 35605478
[TBL] [Abstract][Full Text] [Related]
4. Wedelolactone alleviates cholestatic liver injury by regulating FXR-bile acid-NF-κB/NRF2 axis to reduce bile acid accumulation and its subsequent inflammation and oxidative stress.
Wang MQ; Zhang KH; Liu FL; Zhou R; Zeng Y; Chen AL; Yu Y; Xia Q; Zhu CC; Lin CZ
Phytomedicine; 2024 Jan; 122():155124. PubMed ID: 38014837
[TBL] [Abstract][Full Text] [Related]
5. Glycyrrhetinic acid attenuates endoplasmic reticulum stress-induced hepatocyte apoptosis via CHOP/DR5/Caspase 8 pathway in cholestasis.
Zou B; Zhang S; Zhao J; Song G; Weng F; Xu X; Li F; Jin J; Yan D; Huang K; Liu C; Li Y; Qiu F
Eur J Pharmacol; 2023 Dec; 961():176193. PubMed ID: 37981257
[TBL] [Abstract][Full Text] [Related]
6. NRF2 and FXR dual signaling pathways cooperatively regulate the effects of oleanolic acid on cholestatic liver injury.
Liu J; Liu J; Meng C; Gu Q; Huang C; Liu F; Xia C
Phytomedicine; 2023 Jan; 108():154529. PubMed ID: 36343550
[TBL] [Abstract][Full Text] [Related]
7. Opposite effects of the FXR agonist obeticholic acid on Mafg and Nrf2 mediate the development of acute liver injury in rodent models of cholestasis.
Carino A; Biagioli M; Marchianò S; Fiorucci C; Bordoni M; Roselli R; Di Giorgio C; Baldoni M; Ricci P; Monti MC; Morretta E; Zampella A; Distrutti E; Fiorucci S
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Sep; 1865(9):158733. PubMed ID: 32371093
[TBL] [Abstract][Full Text] [Related]
8. Obeticholic acid protects against lithocholic acid-induced exogenous cell apoptosis during cholestatic liver injury.
Lu Q; Zhu Y; Wang C; Zhang R; Miao Y; Chai Y; Jiang Z; Yu Q
Life Sci; 2024 Jan; 337():122355. PubMed ID: 38104861
[TBL] [Abstract][Full Text] [Related]
9. Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor.
Li T; Xu L; Zheng R; Wang X; Li L; Ji H; Hu Q
Phytomedicine; 2020 Mar; 68():153153. PubMed ID: 32018210
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of hepatoprotective effect of tectorigenin against ANIT-induced cholestatic liver injury: Role of FXR and Nrf2 pathways.
Cao P; Gan J; Wu S; Hu Y; Xia B; Li X; Zeng H; Cheng B; Yu H; Li F; Si L; Huang J
Food Chem Toxicol; 2023 Aug; 178():113914. PubMed ID: 37348807
[TBL] [Abstract][Full Text] [Related]
11. Yangonin protects against cholestasis and hepatotoxity via activation of farnesoid X receptor in vivo and in vitro.
Gao X; Fu T; Wang C; Ning C; Liu K; Liu Z; Sun H; Ma X; Huo X; Yang X; Zou M; Meng Q
Toxicol Appl Pharmacol; 2018 Jun; 348():105-116. PubMed ID: 29660435
[TBL] [Abstract][Full Text] [Related]
12. Yinchen decoction protects against cholic acid diet-induced cholestatic liver injury in mice through liver and ileal FXR signaling.
Song G; Zou B; Zhao J; Weng F; Li Y; Xu X; Zhang S; Yan D; Jin J; Sun X; Liu C; Qiu F
J Ethnopharmacol; 2023 Sep; 313():116560. PubMed ID: 37149065
[TBL] [Abstract][Full Text] [Related]
13. Network pharmacology-based mechanism prediction and pharmacological validation of Xiaoyan Lidan formula on attenuating alpha-naphthylisothiocyanate induced cholestatic hepatic injury in rats.
Wang M; Liu F; Yao Y; Zhang Q; Lu Z; Zhang R; Liu C; Lin C; Zhu C
J Ethnopharmacol; 2021 Apr; 270():113816. PubMed ID: 33444723
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of SRT1720 via the HNF1α/FXR signalling pathway and anti-inflammatory mechanisms in mice with estrogen-induced cholestatic liver injury.
Yu L; Liu X; Li X; Yuan Z; Yang H; Zhang L; Jiang Z
Toxicol Lett; 2016 Dec; 264():1-11. PubMed ID: 27818225
[TBL] [Abstract][Full Text] [Related]
15. Liquiritin alleviates alpha-naphthylisothiocyanate-induced intrahepatic cholestasis through the Sirt1/FXR/Nrf2 pathway.
Yan M; Guo L; Ma J; Yang Y; Tang T; Zhang B; Zhou W; Zou W; Hou Z; Gu H; Gong H
J Appl Toxicol; 2023 Mar; 43(3):350-359. PubMed ID: 36008890
[TBL] [Abstract][Full Text] [Related]
16. Dolomiaea souliei ethyl acetate extract protected against α-naphthylisothiocyanate-induced acute intrahepatic cholestasis through regulation of farnesoid x receptor-mediated bile acid metabolism.
Meng F; Zong W; Wei X; Tao Y; Wang G; Liao Z; Chen M
Phytomedicine; 2021 Jul; 87():153588. PubMed ID: 34091148
[TBL] [Abstract][Full Text] [Related]
17. Picroside II alleviates liver injury induced by alpha-naphthylisothiocyanate through AMPK-FXR pathway.
Li T; Zheng R; Xu L; Zhou M; Wang X; Guo Q; Ji H; Li L
Toxicol Appl Pharmacol; 2020 Dec; 408():115248. PubMed ID: 32976922
[TBL] [Abstract][Full Text] [Related]
18. Artemisia capillaris Thunb. Polysaccharide alleviates cholestatic liver injury through gut microbiota modulation and Nrf2 signaling pathway activation in mice.
Cai J; Zhu Z; Li Y; Li Q; Tian T; Meng Q; Wang T; Ma Y; Wu J
J Ethnopharmacol; 2024 Jun; 327():118009. PubMed ID: 38447617
[TBL] [Abstract][Full Text] [Related]
19. 7, 8-Dihydroxy-4-methyl coumarin alleviates cholestasis via activation of the Farnesoid X receptor in vitro and in vivo.
Refat M; Zhang G; Ahmed A Saad A; Baldi S; Zheng F; Wu X
Chem Biol Interact; 2023 Jan; 370():110331. PubMed ID: 36581201
[TBL] [Abstract][Full Text] [Related]
20. Alisol B 23-acetate protects against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes involved in bile acid homeostasis.
Meng Q; Chen XL; Wang CY; Liu Q; Sun HJ; Sun PY; Huo XK; Liu ZH; Yao JH; Liu KX
Toxicol Appl Pharmacol; 2015 Mar; 283(3):178-86. PubMed ID: 25655198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]